Qui Pharmaceutical Co Ltd

General

Total Cases1

Active Cases1

Patents--

CourtsE.D. Pennsylvania

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
06/20/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	Summons Issued as to QILU PHARMACEUTICAL CO., LTD., Qilu Pharma Inc.. Forwarded To: EMAILED TO PLAINTIFFS COUNSEL on 6/20/2024 (sg) (Entered: 06/20/2024)
06/20/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	NOTICE by MYLAN IRELAND LIMITED, Mylan Specialty L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. (SOLLER, ERIC) (Entered: 06/20/2024)
06/20/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	Attorneys are required by local rule to complete and file both a Civil Cover Sheet and a Designation Form. PLAINTIFF's counsel is directed to file COMPLETED DESIGNATION FORM in this case using the Notice (Other) docket event located in the Notices category. Signature is missing. (sbt) (Entered: 06/20/2024)
06/18/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	Disclosure Statement Form pursuant to FRCP 7.1 by MYLAN IRELAND LIMITED, Mylan Specialty L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(SOLLER, ERIC) (Entered: 06/18/2024)
06/18/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	Disclosure Statement Form pursuant to FRCP 7.1 by MYLAN IRELAND LIMITED, Mylan Specialty L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC..(SOLLER, ERIC) (Entered: 06/18/2024)
06/18/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17547918.), filed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., Mylan Specialty L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet, # 10 Designation Form)(SOLLER, ERIC) (Entered: 06/18/2024) COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17547918.), filed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., Mylan Specialty L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet, # 10 Designation Form)(SOLLER, ERIC) (Entered: 06/18/2024)
06/18/24	Theravance Biopharma R&D IP LLC v. Qui Pharmaceutical Co Ltd 2:24-CV-02689 ( E.D. PA )	COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17547918.), filed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., Mylan Specialty L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet, # 10 Designation Form)(SOLLER, ERIC) (Entered: 06/18/2024) COMPLAINT against All Defendants ( Filing fee $ 405 receipt number APAEDC-17547918.), filed by THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., Mylan Specialty L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet, # 10 Designation Form)(SOLLER, ERIC) (Entered: 06/18/2024)